Loading…

The impact of statins on psychological wellbeing: a systematic review and meta-analysis

Cholesterol-lowering medications such as statins have anti-inflammatory and antioxidant properties, which may be beneficial for treating depression and improving mood. However, evidence regarding their effects remains inconsistent, with some studies reporting links to mood disturbances. We aimed to...

Full description

Saved in:
Bibliographic Details
Published in:BMC medicine 2012-12, Vol.10 (1), p.154-154, Article 154
Main Authors: O'Neil, Adrienne, Sanna, Livia, Redlich, Cassie, Sanderson, Kristy, Jacka, Felice, Williams, Lana J, Pasco, Julie A, Berk, Michael
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c587t-eeac6baec2fd7aa14319b0fce3a8d866eae51597ba3f445488b66273e2080ee3
cites cdi_FETCH-LOGICAL-c587t-eeac6baec2fd7aa14319b0fce3a8d866eae51597ba3f445488b66273e2080ee3
container_end_page 154
container_issue 1
container_start_page 154
container_title BMC medicine
container_volume 10
creator O'Neil, Adrienne
Sanna, Livia
Redlich, Cassie
Sanderson, Kristy
Jacka, Felice
Williams, Lana J
Pasco, Julie A
Berk, Michael
description Cholesterol-lowering medications such as statins have anti-inflammatory and antioxidant properties, which may be beneficial for treating depression and improving mood. However, evidence regarding their effects remains inconsistent, with some studies reporting links to mood disturbances. We aimed to conduct a meta-analysis to determine the impact of statins on psychological wellbeing of individuals with or without hypercholesterolemia. Articles were identified using medical, health, psychiatric and social science databases, evaluated for quality, and data were synthesized and analyzed in RevMan-5 software using a random effects model. The 7 randomized controlled trials included in the analysis represented 2,105 participants. A test for overall effect demonstrated no statistically significant differences in psychological wellbeing between participants receiving statins or a placebo (standardized mean difference (SMD) = -0.08, 95% CI -0.29 to 0.12; P = 0.42). Sensitivity analyses were conducted to separately analyze depression (n = 5) and mood (n = 2) outcomes; statins were associated with statistically significant improvements in mood scores (SMD = -0.43, 95% CI -0.61 to -0.24). Our findings refute evidence of negative effects of statins on psychological outcomes, providing some support for mood-related benefits. Future studies could examine the effects of statins in depressed populations.
doi_str_mv 10.1186/1741-7015-10-154
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_f837beb5f2924e23aa498de38e91f030</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A534167738</galeid><doaj_id>oai_doaj_org_article_f837beb5f2924e23aa498de38e91f030</doaj_id><sourcerecordid>A534167738</sourcerecordid><originalsourceid>FETCH-LOGICAL-c587t-eeac6baec2fd7aa14319b0fce3a8d866eae51597ba3f445488b66273e2080ee3</originalsourceid><addsrcrecordid>eNptks2LEzEUwAdR3HX17kkGBPEyaz4nGQ_CsvixUPBS8BheMi9tysykTqZb-t-btmtpRUJIePm9X8LLK4q3lNxSqutPVAlaKUJlRUlFpXhWXJ9Cz8_2V8WrlFaEMKmUeFlcMc5IzYm-Ln7Nl1iGfg1uKqMv0wRTGFIZh3Kddm4Zu7gIDrpyi11nMQyLzyWUaZcm7DPpyhEfA25LGNqyxwkqGKDbpZBeFy88dAnfPK03xfzb1_n9j2r28_vD_d2sclKrqUIEV1tAx3yrAKjgtLHEO-SgW13XCCipbJQF7oWQQmtb10xxZEQTRH5TPBy1bYSVWY-hh3FnIgRzCMRxYWDM7-zQeM2VRSs9a5hAxgFEo1vkGhvqCSfZNTu60hbXG3th6zbrPG2eJqGhmlBoVGuUotwIZsFY3xKDwjLe-IY04LLuy1GXXT22DodphO7CenkyhKVZxEfDZZ39Mgs-PgnG-HuDaTJ9SC7_AwwYN8lQputGiEbojL7_B13FzZi_4kBJqlgtz6gF5HqEwcd8r9tLzZ3kgtZK8T11-x8qjxb74OKAPuT4RcKHs4QlQjctU-w2U4hDugTJEXRjTGlEfyoGJWbfz2bfsGbfsIeIFDnl3XkRTwl_G5j_ATff7pA</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1285172658</pqid></control><display><type>article</type><title>The impact of statins on psychological wellbeing: a systematic review and meta-analysis</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>O'Neil, Adrienne ; Sanna, Livia ; Redlich, Cassie ; Sanderson, Kristy ; Jacka, Felice ; Williams, Lana J ; Pasco, Julie A ; Berk, Michael</creator><creatorcontrib>O'Neil, Adrienne ; Sanna, Livia ; Redlich, Cassie ; Sanderson, Kristy ; Jacka, Felice ; Williams, Lana J ; Pasco, Julie A ; Berk, Michael</creatorcontrib><description>Cholesterol-lowering medications such as statins have anti-inflammatory and antioxidant properties, which may be beneficial for treating depression and improving mood. However, evidence regarding their effects remains inconsistent, with some studies reporting links to mood disturbances. We aimed to conduct a meta-analysis to determine the impact of statins on psychological wellbeing of individuals with or without hypercholesterolemia. Articles were identified using medical, health, psychiatric and social science databases, evaluated for quality, and data were synthesized and analyzed in RevMan-5 software using a random effects model. The 7 randomized controlled trials included in the analysis represented 2,105 participants. A test for overall effect demonstrated no statistically significant differences in psychological wellbeing between participants receiving statins or a placebo (standardized mean difference (SMD) = -0.08, 95% CI -0.29 to 0.12; P = 0.42). Sensitivity analyses were conducted to separately analyze depression (n = 5) and mood (n = 2) outcomes; statins were associated with statistically significant improvements in mood scores (SMD = -0.43, 95% CI -0.61 to -0.24). Our findings refute evidence of negative effects of statins on psychological outcomes, providing some support for mood-related benefits. Future studies could examine the effects of statins in depressed populations.</description><identifier>ISSN: 1741-7015</identifier><identifier>EISSN: 1741-7015</identifier><identifier>DOI: 10.1186/1741-7015-10-154</identifier><identifier>PMID: 23206308</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject>Affect - drug effects ; anti-inflammatory ; Cholesterol ; cytokines ; depression ; Depression - drug therapy ; Depression, Mental ; Dosage and administration ; Drug therapy ; Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi ; Health Sciences ; Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology ; Hypercholesterolemia ; Hälsovetenskap ; Medical and Health Sciences ; Medical research ; Medicin och hälsovetenskap ; Mental depression ; Mental Health ; mood ; oxidative ; Pharmaceutical industry ; Psychological aspects ; Public Health, Global Health, Social Medicine and Epidemiology ; Risk factors ; Statins ; Studies</subject><ispartof>BMC medicine, 2012-12, Vol.10 (1), p.154-154, Article 154</ispartof><rights>COPYRIGHT 2012 BioMed Central Ltd.</rights><rights>2012 O'Neil et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</rights><rights>Copyright ©2012 O'Neil et al; licensee BioMed Central Ltd. 2012 O'Neil et al; licensee BioMed Central Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c587t-eeac6baec2fd7aa14319b0fce3a8d866eae51597ba3f445488b66273e2080ee3</citedby><cites>FETCH-LOGICAL-c587t-eeac6baec2fd7aa14319b0fce3a8d866eae51597ba3f445488b66273e2080ee3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3568015/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1285172658?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,725,778,782,883,25740,27911,27912,36999,37000,44577,53778,53780</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23206308$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://lup.lub.lu.se/record/3674821$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>O'Neil, Adrienne</creatorcontrib><creatorcontrib>Sanna, Livia</creatorcontrib><creatorcontrib>Redlich, Cassie</creatorcontrib><creatorcontrib>Sanderson, Kristy</creatorcontrib><creatorcontrib>Jacka, Felice</creatorcontrib><creatorcontrib>Williams, Lana J</creatorcontrib><creatorcontrib>Pasco, Julie A</creatorcontrib><creatorcontrib>Berk, Michael</creatorcontrib><title>The impact of statins on psychological wellbeing: a systematic review and meta-analysis</title><title>BMC medicine</title><addtitle>BMC Med</addtitle><description>Cholesterol-lowering medications such as statins have anti-inflammatory and antioxidant properties, which may be beneficial for treating depression and improving mood. However, evidence regarding their effects remains inconsistent, with some studies reporting links to mood disturbances. We aimed to conduct a meta-analysis to determine the impact of statins on psychological wellbeing of individuals with or without hypercholesterolemia. Articles were identified using medical, health, psychiatric and social science databases, evaluated for quality, and data were synthesized and analyzed in RevMan-5 software using a random effects model. The 7 randomized controlled trials included in the analysis represented 2,105 participants. A test for overall effect demonstrated no statistically significant differences in psychological wellbeing between participants receiving statins or a placebo (standardized mean difference (SMD) = -0.08, 95% CI -0.29 to 0.12; P = 0.42). Sensitivity analyses were conducted to separately analyze depression (n = 5) and mood (n = 2) outcomes; statins were associated with statistically significant improvements in mood scores (SMD = -0.43, 95% CI -0.61 to -0.24). Our findings refute evidence of negative effects of statins on psychological outcomes, providing some support for mood-related benefits. Future studies could examine the effects of statins in depressed populations.</description><subject>Affect - drug effects</subject><subject>anti-inflammatory</subject><subject>Cholesterol</subject><subject>cytokines</subject><subject>depression</subject><subject>Depression - drug therapy</subject><subject>Depression, Mental</subject><subject>Dosage and administration</subject><subject>Drug therapy</subject><subject>Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi</subject><subject>Health Sciences</subject><subject>Humans</subject><subject>Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology</subject><subject>Hypercholesterolemia</subject><subject>Hälsovetenskap</subject><subject>Medical and Health Sciences</subject><subject>Medical research</subject><subject>Medicin och hälsovetenskap</subject><subject>Mental depression</subject><subject>Mental Health</subject><subject>mood</subject><subject>oxidative</subject><subject>Pharmaceutical industry</subject><subject>Psychological aspects</subject><subject>Public Health, Global Health, Social Medicine and Epidemiology</subject><subject>Risk factors</subject><subject>Statins</subject><subject>Studies</subject><issn>1741-7015</issn><issn>1741-7015</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptks2LEzEUwAdR3HX17kkGBPEyaz4nGQ_CsvixUPBS8BheMi9tysykTqZb-t-btmtpRUJIePm9X8LLK4q3lNxSqutPVAlaKUJlRUlFpXhWXJ9Cz8_2V8WrlFaEMKmUeFlcMc5IzYm-Ln7Nl1iGfg1uKqMv0wRTGFIZh3Kddm4Zu7gIDrpyi11nMQyLzyWUaZcm7DPpyhEfA25LGNqyxwkqGKDbpZBeFy88dAnfPK03xfzb1_n9j2r28_vD_d2sclKrqUIEV1tAx3yrAKjgtLHEO-SgW13XCCipbJQF7oWQQmtb10xxZEQTRH5TPBy1bYSVWY-hh3FnIgRzCMRxYWDM7-zQeM2VRSs9a5hAxgFEo1vkGhvqCSfZNTu60hbXG3th6zbrPG2eJqGhmlBoVGuUotwIZsFY3xKDwjLe-IY04LLuy1GXXT22DodphO7CenkyhKVZxEfDZZ39Mgs-PgnG-HuDaTJ9SC7_AwwYN8lQputGiEbojL7_B13FzZi_4kBJqlgtz6gF5HqEwcd8r9tLzZ3kgtZK8T11-x8qjxb74OKAPuT4RcKHs4QlQjctU-w2U4hDugTJEXRjTGlEfyoGJWbfz2bfsGbfsIeIFDnl3XkRTwl_G5j_ATff7pA</recordid><startdate>20121203</startdate><enddate>20121203</enddate><creator>O'Neil, Adrienne</creator><creator>Sanna, Livia</creator><creator>Redlich, Cassie</creator><creator>Sanderson, Kristy</creator><creator>Jacka, Felice</creator><creator>Williams, Lana J</creator><creator>Pasco, Julie A</creator><creator>Berk, Michael</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><general>BMC</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>ADTPV</scope><scope>AGCHP</scope><scope>AOWAS</scope><scope>D8T</scope><scope>D95</scope><scope>ZZAVC</scope><scope>DOA</scope></search><sort><creationdate>20121203</creationdate><title>The impact of statins on psychological wellbeing: a systematic review and meta-analysis</title><author>O'Neil, Adrienne ; Sanna, Livia ; Redlich, Cassie ; Sanderson, Kristy ; Jacka, Felice ; Williams, Lana J ; Pasco, Julie A ; Berk, Michael</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c587t-eeac6baec2fd7aa14319b0fce3a8d866eae51597ba3f445488b66273e2080ee3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Affect - drug effects</topic><topic>anti-inflammatory</topic><topic>Cholesterol</topic><topic>cytokines</topic><topic>depression</topic><topic>Depression - drug therapy</topic><topic>Depression, Mental</topic><topic>Dosage and administration</topic><topic>Drug therapy</topic><topic>Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi</topic><topic>Health Sciences</topic><topic>Humans</topic><topic>Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology</topic><topic>Hypercholesterolemia</topic><topic>Hälsovetenskap</topic><topic>Medical and Health Sciences</topic><topic>Medical research</topic><topic>Medicin och hälsovetenskap</topic><topic>Mental depression</topic><topic>Mental Health</topic><topic>mood</topic><topic>oxidative</topic><topic>Pharmaceutical industry</topic><topic>Psychological aspects</topic><topic>Public Health, Global Health, Social Medicine and Epidemiology</topic><topic>Risk factors</topic><topic>Statins</topic><topic>Studies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>O'Neil, Adrienne</creatorcontrib><creatorcontrib>Sanna, Livia</creatorcontrib><creatorcontrib>Redlich, Cassie</creatorcontrib><creatorcontrib>Sanderson, Kristy</creatorcontrib><creatorcontrib>Jacka, Felice</creatorcontrib><creatorcontrib>Williams, Lana J</creatorcontrib><creatorcontrib>Pasco, Julie A</creatorcontrib><creatorcontrib>Berk, Michael</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Virology and AIDS Abstracts</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>SwePub</collection><collection>SWEPUB Lunds universitet full text</collection><collection>SwePub Articles</collection><collection>SWEPUB Freely available online</collection><collection>SWEPUB Lunds universitet</collection><collection>SwePub Articles full text</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>BMC medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>O'Neil, Adrienne</au><au>Sanna, Livia</au><au>Redlich, Cassie</au><au>Sanderson, Kristy</au><au>Jacka, Felice</au><au>Williams, Lana J</au><au>Pasco, Julie A</au><au>Berk, Michael</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The impact of statins on psychological wellbeing: a systematic review and meta-analysis</atitle><jtitle>BMC medicine</jtitle><addtitle>BMC Med</addtitle><date>2012-12-03</date><risdate>2012</risdate><volume>10</volume><issue>1</issue><spage>154</spage><epage>154</epage><pages>154-154</pages><artnum>154</artnum><issn>1741-7015</issn><eissn>1741-7015</eissn><abstract>Cholesterol-lowering medications such as statins have anti-inflammatory and antioxidant properties, which may be beneficial for treating depression and improving mood. However, evidence regarding their effects remains inconsistent, with some studies reporting links to mood disturbances. We aimed to conduct a meta-analysis to determine the impact of statins on psychological wellbeing of individuals with or without hypercholesterolemia. Articles were identified using medical, health, psychiatric and social science databases, evaluated for quality, and data were synthesized and analyzed in RevMan-5 software using a random effects model. The 7 randomized controlled trials included in the analysis represented 2,105 participants. A test for overall effect demonstrated no statistically significant differences in psychological wellbeing between participants receiving statins or a placebo (standardized mean difference (SMD) = -0.08, 95% CI -0.29 to 0.12; P = 0.42). Sensitivity analyses were conducted to separately analyze depression (n = 5) and mood (n = 2) outcomes; statins were associated with statistically significant improvements in mood scores (SMD = -0.43, 95% CI -0.61 to -0.24). Our findings refute evidence of negative effects of statins on psychological outcomes, providing some support for mood-related benefits. Future studies could examine the effects of statins in depressed populations.</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>23206308</pmid><doi>10.1186/1741-7015-10-154</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1741-7015
ispartof BMC medicine, 2012-12, Vol.10 (1), p.154-154, Article 154
issn 1741-7015
1741-7015
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_f837beb5f2924e23aa498de38e91f030
source Publicly Available Content Database; PubMed Central
subjects Affect - drug effects
anti-inflammatory
Cholesterol
cytokines
depression
Depression - drug therapy
Depression, Mental
Dosage and administration
Drug therapy
Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi
Health Sciences
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology
Hypercholesterolemia
Hälsovetenskap
Medical and Health Sciences
Medical research
Medicin och hälsovetenskap
Mental depression
Mental Health
mood
oxidative
Pharmaceutical industry
Psychological aspects
Public Health, Global Health, Social Medicine and Epidemiology
Risk factors
Statins
Studies
title The impact of statins on psychological wellbeing: a systematic review and meta-analysis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T15%3A14%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20impact%20of%20statins%20on%20psychological%20wellbeing:%20a%20systematic%20review%20and%20meta-analysis&rft.jtitle=BMC%20medicine&rft.au=O'Neil,%20Adrienne&rft.date=2012-12-03&rft.volume=10&rft.issue=1&rft.spage=154&rft.epage=154&rft.pages=154-154&rft.artnum=154&rft.issn=1741-7015&rft.eissn=1741-7015&rft_id=info:doi/10.1186/1741-7015-10-154&rft_dat=%3Cgale_doaj_%3EA534167738%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c587t-eeac6baec2fd7aa14319b0fce3a8d866eae51597ba3f445488b66273e2080ee3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1285172658&rft_id=info:pmid/23206308&rft_galeid=A534167738&rfr_iscdi=true